Abstract
Stem cell biobanks can be understood as repositories of stem cells and stem cell lines including the data associated with the biological material. Such biobanks have widely differing extents, characters and purposes. Some are very large and serve broad-spectrum purposes. Others are smaller and have more distinct aims. Some are public, others are commercial. Altogether the area of stem cell banks is highly complex, which implies a regulatory challenge for legislators. This paper aims at clarifying how stem cell banks are regulated in international law with a special focus on the balancing of interests of different stakeholders. Tissue donors may have various interests in regards to stored stem cell samples, especially an interest in self-determination and privacy protection. These interests must be balanced against the interests of other actors, not least those patients who can benefit from the development of new treatment but also the interest of society at large in development of new knowledge. New issue arises in situations where stem cell research is moved from the laboratory to the clinic. The change of purposes associated with the translation of research into clinical practise gives rise to special regulatory concerns and challenges, especially in regards to tissue donor’s right to self-determination. The paper concludes that the international regulation only to a limited extent refer explicitly to how the transition from laboratory research to stem cell treatment should be dealt with, and that there is a need for clarification in international law of how to tackle this challenge.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Isasi RM, Knoppers BM. Governing stem cell banks and registries: emerging issues. Stem Cell Res. 2009; 3:96–105.
Hoeyer K, Nexoe S, Hartlev M, Koch L. Embryonic entitlements: the coproduction of personhood and commodities. Body Soc. 2009; 15:1–24.
Honnefelder L. Science, law and ethics: the biomedicine convention as an ethico-legal response to current scientific challenges, in: Gevers JKM, Hondius EH, and Hubben JH, eds. Health law, human rights and the biomedicine convention: essays in honour of Henriette Roscam Abbing. Leiden/Boston: Martinus Nijhoff Publishers; 2005. p. 13–22.
Council of Europe. Convention for the protection of human rights and dignity of the human being in connection with application of biology and biomedicine: convention on human rights and biomedicine. Oviedo, Spain; 1997.
United Nations Educational, Scientific and Cultural Organisation. Universal declaration on bioethics and human rights. Paris, France; 2005.
World Health Organization. A declaration of the promotion of patients rights in Europe. Amsterdam, the Netherlands; 1994.
World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human beings. Helsinki, Finland; 1964.
European Union. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Brussels, Belgium; 1995.
World Health Organization. Constitution of the World Health Organization. New York; 1946.
United Nations. International covenant on economic, social and cultural rights. New York; 1966.
Council of Europe. Additional protocol to the convention on human rights and biomedicine on transplantation of organs and human tissue. Strasbourg, France; 2002.
Elster A, Damaschun A, Kurtz A, Stacey G, Arán B, Veiga A et al. The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res. 2009; 2:101–107.
Council of Europe. Recommendation Rec (2006)4 of the Committee of Ministers to member states on research on biological materials of human origin. Strasbourg, France; 2006.
United Nations. General assembly resolution A/RES/59/280: United Nations declaration on human cloning. New York; 2005.
United Nations Educational, Scientific and Cultural Organisation. Universal declaration on human genetic data. Paris, France; 2003.
Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Washington, DC: U.S. Government Printing Office, 1949; 2:181–2.
European Group on Ethics in Science and New Technologies. Ethical aspects of human tissue banking. Brussels, Belgium; 1998.
Gevers S. Human tissue research with particular reference to biobanking, in: Gevers JKM, Hondius EH, and Hubben JH, eds. Health law, human rights and the biomedicine convention: essays in honour of Henriette Roscam Abbing. Leiden/Boston: Martinus Nijhoff Publishers; 2005. p. 231–43.
Rouillé-Mirza S, Wright J. Comparative study on the implementation and effect of directive 95/46/EC on data protection in Europe: medical research, in: Beyleveld D, Towend D, Rouillé-Mirza S, and Wright J, eds. The data protection directive and medical research across Europe. Aldershot/Burlington: Ashgate; 2004. p. 189–230.
Brown N, Faulkner A, Kent J, Michael M. Regulating hybrids: “making a mess” and “cleaning up” in tissue engineering and transpecies transplantation. Soc. Theory Health. 2006; 4:1–24.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hartlev, M. (2011). Banks, Repositories and Registries of Stem Cell Lines: The Challenges to Legal Regulation. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-60761-959-8_20
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-958-1
Online ISBN: 978-1-60761-959-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)